explore -WSS

explore

author：Wikipedia 2025-10-02 21:05:13 - browse：56

he exterior of the U.S. Capitol building is seen at sunrise — Sarah Silbiger/Getty Images

WASHINGTON — Panels in both the House and Senate have now passed restrictions to drug middlemen business practices, increasing the chances of those measures being included in future government spending bills.

The bipartisan reforms to pharmacy benefit managers were among 21 bills that the House Energy & Commerce health subcommittee passed today. The policies are not identical, but at least three PBM reforms have been passed by panels in both chambers:

One that would replace PBM fees that are tied to a percentage of drug prices with flat fees
Another that would require Medicare to create standard performance measures on which PBMs base pharmacy payments
A third that would require PBMs to report a host of information, including drug costs, savings, beneficiary out-of-pocket costs, payments to pharmacies, and the amount of business directed to PBM-owned pharmacies

The Energy & Commerce subcommittee also passed other bills that mirror legislation that Senate Finance also has passed. That includes legislation to ensure seniors pay no more for drugs than insurers, and a measure that lets insurers add less-expensive biosimilars to formularies mid-year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Maisha Meds is a PBM, but don't call it that

entertainment

WSS

There's an unseen cost to disruptive road

Medicare bonuses could stop drug shortages under Senate plan

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

The inclusion problem at the heart of rehabilitation research

Medicare drug price lawsuits could be good politics for Biden

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

hotspot

explore

Wikipedia

Hepatitis C has a cure — but many Americans still lack access to it

Prior authorization reform is both possible and imperative

Peter Hotez and the public health issue of online harassment

Dog Aging Project founders on what lies ahead after losing funding

Wildfire smoke exposes gaps in outdoor worker protections

Flu vaccine reformulation won't be easy, manufacturers warn

Apple is now the first public company to be valued at $3 trillion

Latigo launches with $135 million for Vertex

Medical leaders decry Supreme Court decision on affirmative action

Medicare bonuses could stop drug shortages under Senate plan

knowledge

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Juul documents reveal insider tactics on political lobbying

Juul documents reveal insider tactics on political lobbying

Future doctors need a strong humanities education

Latigo launches with $135 million for Vertex

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

knowledge

knowledge

entertainment

focus